HCPCS J0895
Injection, deferoxamine mesylate, 500 mg
HCPCS Information
- HCPCS Code: J0895
- The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J0895 identifies the type of service or supply used while any of the 14 NDC codes below could be used to specify the exact drug used.
- Short Description
- Deferoxamine mesylate inj
- Long Description
- Injection, deferoxamine mesylate, 500 mg
- Pricing Indicator
- Drugs
- Multiple Pricing Indicator
- Not applicable as HCPCS priced under one methodology
- Coverage Description
- Special coverage instructions apply
- BETOS Type of Service
- Other drugs
- Medicare Payment Limit
- $9.02
- Medicare Co-Insurance Percentage
- 20.000%
- HCPCS Classification
- List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)
HCPCS Crossover to NDC Codes
The NDC codes below allow precise billing based on the specific manufacturer and medication used:
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0078-0467 | Desferal | Deferoxamine Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 0409-2336 | Deferoxamine Mesylate | Hospira, Inc. | |||||
| 0409-2336 | Deferoxamine Mesylate | Hospira, Inc. | |||||
| 0409-2337 | Deferoxamine Mesylate | Deferoxamine Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
| 0409-2337 | Deferoxamine Mesylate | Hospira, Inc. | |||||
| 47781-623 | Deferoxamine Mesylate | Alvogen Inc. | |||||
| 47781-624 | Deferoxamine Mesylate | Alvogen Inc. | |||||
| 52609-4504 | Deferoxamine Mesylate | Apopharma Usa, Inc. | INACTIVATED | ||||
| 52609-4505 | Deferoxamine Mesylate | Apopharma Usa, Inc. | INACTIVATED | ||||
| 60505-6236 | Deferoxamine Mesylate | Deferoxamine Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous; Subcutaneous | Apotex Corp. | ACTIVE | |
| 60505-6237 | Deferoxamine Mesylate | Deferoxamine Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous | Apotex Corp. | ACTIVE | |
| 60505-6238 | Deferoxamine Mesylate | Apotex Corp. | |||||
| 63323-597 | Deferoxamine | Deferoxamine Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
| 63323-599 | Deferoxamine | Deferoxamine Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE |